• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Dapa

Anonymous

Guest
Any word on how we are even comparable to Invokana. How do you respond when the doctor says HOW DO YOU DIFFER FROM INVOKANA. I know start begging and change the subject
 

<



Any word on how we are even comparable to Invokana. How do you respond when the doctor says HOW DO YOU DIFFER FROM INVOKANA. I know start begging and change the subject

In reading on this drug there appears to be nothing that Invokana cannot offer but bladder cancer and less effectiveness. Bladder cancer will be be the undoing of this drug. Why write it when there is Invokana with no risk. Unbelievable . Come on BJ. LET'S HERE YOUR MOTIVATION